Holland & Knight Completes $115 Million IPO for Healthcare SPAC
MIAMI (July 27, 2017) – Holland & Knight represented underwriters Ladenburg Thalmann & Co., B. Riley & Co., FBR, Chardan and I-Bankers Securities in the initial public offering of KBL Merger Corp. IV, a special-purpose acquisition company (SPAC). The offering priced on June 1 and closed on June 7, resulting in gross proceeds to the SPAC of $100 million. An additional $15 million was raised for the SPAC by the end of June through an over-allotment option exercised in full by the underwriters.
KBL Merger Corp. IV is led by prominent healthcare investor Marlene Krauss, M.D., and was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company intends to focus its search for a target business in the healthcare and related wellness industry.
Ladenburg Thalmann & Co. Inc., a subsidiary of Ladenburg Thalmann Financial Services Inc. (NYSE MKT: LTS), B. Riley & Co. and FBR acted as joint book-running managers, Chardan acted as lead manager and I-Bankers Securities, Inc. acted as co-manager for the offering.
Holland & Knight Miami-based Partner Bradley Houser and Associate Shane Segarra led the firm’s representation of the underwriters. They are among a small group of attorneys nationwide who have experience structuring, advising and taking public SPACs, a specialized legal practice area blending capital markets and corporate finance work.